IDR 810.0
(0.62%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 191.39 Billion IDR | -41.07% |
2022 | 324.76 Billion IDR | -36.94% |
2021 | 515.04 Billion IDR | 180.61% |
2020 | 183.54 Billion IDR | 50.04% |
2019 | 122.33 Billion IDR | 9.05% |
2018 | 112.18 Billion IDR | 65.66% |
2017 | 67.71 Billion IDR | 119.03% |
2016 | 30.91 Billion IDR | 103.99% |
2015 | 15.15 Billion IDR | 43.72% |
2014 | 10.54 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | 97.17 Billion IDR | -3.95% |
2024 Q2 | 101.17 Billion IDR | 15.39% |
2024 Q1 | 87.68 Billion IDR | 37.71% |
2023 Q3 | 41.59 Billion IDR | -7.44% |
2023 FY | 191.39 Billion IDR | -41.07% |
2023 Q1 | 41.2 Billion IDR | -9.99% |
2023 Q2 | 44.93 Billion IDR | 9.05% |
2023 Q4 | 63.66 Billion IDR | 53.09% |
2022 Q2 | 94.36 Billion IDR | -44.82% |
2022 Q3 | 13.61 Billion IDR | -85.58% |
2022 Q4 | 45.77 Billion IDR | 236.31% |
2022 FY | 324.76 Billion IDR | -36.94% |
2022 Q1 | 171.01 Billion IDR | 16.03% |
2021 Q3 | 162.73 Billion IDR | 46.55% |
2021 FY | 515.04 Billion IDR | 180.61% |
2021 Q4 | 147.39 Billion IDR | -9.43% |
2021 Q1 | 90.91 Billion IDR | 29.02% |
2021 Q2 | 111.04 Billion IDR | 22.15% |
2020 Q1 | 32.9 Billion IDR | 5.65% |
2020 Q2 | 30.61 Billion IDR | -6.95% |
2020 FY | 183.54 Billion IDR | 50.04% |
2020 Q4 | 70.46 Billion IDR | 37.8% |
2020 Q3 | 51.13 Billion IDR | 67.01% |
2019 Q4 | 31.14 Billion IDR | 4.34% |
2019 FY | 122.33 Billion IDR | 9.05% |
2019 Q3 | 29.85 Billion IDR | -3.3% |
2019 Q2 | 30.87 Billion IDR | -2.49% |
2019 Q1 | 31.65 Billion IDR | -2.64% |
2018 Q3 | 30.07 Billion IDR | 18.98% |
2018 FY | 112.18 Billion IDR | 65.66% |
2018 Q4 | 32.51 Billion IDR | 8.11% |
2018 Q1 | 24.3 Billion IDR | 18.48% |
2018 Q2 | 25.28 Billion IDR | 4.03% |
2017 FY | 67.71 Billion IDR | 119.03% |
2017 Q1 | 8.14 Billion IDR | -51.69% |
2017 Q2 | 15.66 Billion IDR | 92.35% |
2017 Q3 | 23.4 Billion IDR | 49.4% |
2017 Q4 | 20.51 Billion IDR | -12.34% |
2016 Q3 | 8.28 Billion IDR | 185.34% |
2016 FY | 30.91 Billion IDR | 103.99% |
2016 Q2 | 2.9 Billion IDR | -0.0% |
2016 Q1 | 2.9 Billion IDR | 0.0% |
2016 Q4 | 16.85 Billion IDR | 103.38% |
2015 FY | 15.15 Billion IDR | 43.72% |
2014 FY | 10.54 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Hetzer Medical Indonesia Tbk | -2.5 Billion IDR | 7744.312% |
PT Jayamas Medica Industri Tbk | 302.56 Billion IDR | 36.742% |
Maja Agung Latexindo Tbk. | 744.63 Million IDR | -25603.197% |